ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 121 filers reported holding ANAPTYSBIO INC in Q4 2019. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $94,330,000 | -34.8% | 2,695,922 | +5.1% | 0.23% | -35.6% |
| Q2 2019 | $144,769,000 | -25.9% | 2,565,922 | -4.0% | 0.36% | -26.2% |
| Q1 2019 | $195,320,000 | +33.4% | 2,673,784 | +16.5% | 0.49% | +20.2% |
| Q4 2018 | $146,398,000 | +12.8% | 2,295,000 | +76.5% | 0.41% | +40.5% |
| Q3 2018 | $129,732,000 | +17.9% | 1,300,315 | -16.1% | 0.29% | +14.7% |
| Q2 2018 | $110,058,000 | -23.2% | 1,549,244 | +12.5% | 0.25% | -24.6% |
| Q1 2018 | $143,370,000 | +13.9% | 1,377,500 | +10.2% | 0.33% | +17.2% |
| Q4 2017 | $125,900,000 | +195.5% | 1,250,000 | +2.5% | 0.28% | +174.0% |
| Q3 2017 | $42,604,000 | +234.9% | 1,218,986 | +129.3% | 0.10% | +235.5% |
| Q2 2017 | $12,723,000 | +87.1% | 531,676 | +117.0% | 0.03% | +82.4% |
| Q1 2017 | $6,799,000 | – | 245,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |